350 is the total number of securities RTW INVESTMENTS, LP has owned. The longest RTW INVESTMENTS, LP has owned a single stock is 36 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
ALNY | ALNYLAM PHARMACEUTICAL... | 36 | 36 | 2.04% | 8.96% | 19.74% | Q4 2014 | Q3 2023 | 36 |
MASI | MASIMO CORP | 31 | 1 | 0.31% | 2.66% | 5.77% | Q3 2015 | Q3 2023 | 32 |
LJPC | LA JOLLA PHARMACEUTICA... | 31 | 31 | 0.13% | 3.46% | 9.67% | Q4 2014 | Q2 2022 | 31 |
RGNX | REGENXBIO INC | 30 | 30 | 0.21% | 2.52% | 10.76% | Q3 2015 | Q4 2022 | 30 |
AGEN | AGENUS INC | 29 | 29 | 0.08% | 2.43% | 8.99% | Q2 2015 | Q2 2022 | 29 |
PTCT | PTC THERAPEUTICS INC | 28 | 28 | 2.97% | 6.42% | 12.77% | Q4 2016 | Q3 2023 | 28 |
DRNA | DICERNA PHARMACEUTICAL... | 28 | 28 | 1.39% | 4.56% | 10.75% | Q4 2014 | Q3 2021 | 28 |
MRTX | MIRATI THERAPEUTICS INC | 20 | 6 | 0.15% | 2.93% | 6.22% | Q3 2015 | Q3 2023 | 26 |
ARGX | ARGENX SE | 26 | 26 | 0.10% | 1.23% | 5.26% | Q2 2017 | Q3 2023 | 26 |
VCEL | VERICEL CORP | 24 | 24 | 1.19% | 2.35% | 3.92% | Q4 2017 | Q3 2023 | 24 |
RCKT | ROCKET PHARMACEUTICALS... | 23 | 23 | 5.04% | 11.74% | 24.58% | Q1 2018 | Q3 2023 | 23 |
NTRA | NATERA INC | 17 | 1 | 0.07% | 1.67% | 3.13% | Q3 2015 | Q3 2023 | 23 |
ESTA | Establishment Labs Hol... | 21 | 21 | 1.04% | 2.34% | 3.37% | Q3 2018 | Q3 2023 | 21 |
BMY | BRISTOL MYERS SQUIBB CO | 20 | 20 | 1.88% | 5.24% | 12.45% | Q2 2015 | Q1 2020 | 20 |
ACHN | Achillion Pharmaceutic... | 11 | 9 | 0.44% | 4.47% | 7.35% | Q4 2014 | Q4 2019 | 20 |
AXNX | Axonics Modulation Tec... | 20 | 20 | 0.52% | 1.76% | 3.36% | Q4 2018 | Q3 2023 | 20 |
ABUS | ARBUTUS BIOPHARMA CORP | 20 | 20 | 0.14% | 1.49% | 5.69% | Q1 2017 | Q4 2021 | 20 |
AXSM | AXSOME THERAPEUTICS INC | 19 | 19 | 0.58% | 2.64% | 6.62% | Q1 2019 | Q3 2023 | 19 |
APYX | APYX MEDICAL CORPORATION | 19 | 19 | 0.12% | 0.59% | 1.36% | Q1 2019 | Q3 2023 | 19 |
STOK | STOKE THERAPEUTICS INC | 18 | 18 | 0.36% | 2.15% | 4.94% | Q2 2019 | Q3 2023 | 18 |
MIST | Milestone Pharmaceutic... | 18 | 18 | 0.18% | 0.99% | 4.86% | Q2 2019 | Q3 2023 | 18 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 17 | 17 | 0.01% | 1.47% | 4.01% | Q1 2018 | Q1 2022 | 17 |
PTGX | PROTAGONIST THERAPEUTI... | 17 | 17 | 0.47% | 1.41% | 2.85% | Q3 2019 | Q3 2023 | 17 |
TXG | 10X GENOMICS INC | 17 | 17 | 0.01% | 1.20% | 2.17% | Q3 2019 | Q3 2023 | 17 |
DERMTECH INC | 17 | 17 | 0.08% | 0.91% | 2.47% | Q3 2019 | Q3 2023 | 17 | |
JNJ | JOHNSON & JOHNSON | 17 | 17 | 0.06% | 0.47% | 0.97% | Q4 2018 | Q4 2022 | 17 |
XGN | EXAGEN INC | 17 | 17 | 0.07% | 0.28% | 0.86% | Q3 2019 | Q3 2023 | 17 |
ILMN | ILLUMINA INC | 13 | 1 | 0.54% | 2.18% | 3.68% | Q2 2018 | Q3 2023 | 16 |
AVDL | AVADEL PHARMACEUTICALS... | 16 | 16 | 0.36% | 0.96% | 2.14% | Q4 2019 | Q3 2023 | 16 |
RLMD | RELMADA THERAPEUTICS INC | 16 | 16 | 0.10% | 0.93% | 2.26% | Q4 2019 | Q3 2023 | 16 |
PRQR | PROQR THRAPEUTICS N V | 15 | 15 | 0.13% | 1.29% | 4.33% | Q3 2018 | Q1 2022 | 15 |
CSTL | CASTLE BIOSCIENCES INC | 15 | 15 | 0.12% | 0.64% | 0.92% | Q3 2019 | Q1 2023 | 15 |
CTMX | CYTOMX THERAPEUTICS INC | 15 | 15 | 0.11% | 0.38% | 1.28% | Q4 2018 | Q2 2022 | 15 |
BWAY | BRAINSWAY LTD | 15 | 15 | 0.08% | 0.24% | 0.45% | Q2 2019 | Q4 2022 | 15 |
CLDX | CELLDEX THERAPEUTICS I... | 14 | 14 | 0.96% | 1.96% | 3.18% | Q2 2020 | Q3 2023 | 14 |
CORI | CORIUM INTL INC | 14 | 14 | 1.01% | 1.86% | 3.23% | Q2 2015 | Q3 2018 | 14 |
RNA | AVIDITY BIOSCIENCES INC | 14 | 14 | 0.90% | 1.86% | 2.92% | Q2 2020 | Q3 2023 | 14 |
BCRX | BioCryst Pharmaceutica... | 13 | 13 | 2.03% | 6.22% | 10.17% | Q4 2014 | Q4 2017 | 13 |
MYOK | MYOKARDIA INC | 13 | 13 | 0.94% | 1.86% | 3.08% | Q3 2017 | Q3 2020 | 13 |
CYTK | Cytokinetics Inc Private | 13 | 13 | 0.60% | 1.59% | 2.88% | Q3 2020 | Q3 2023 | 13 |
VIVE | VIVEVE MED INC | 13 | 13 | 0.09% | 1.07% | 1.91% | Q2 2016 | Q2 2019 | 13 |
GH | GUARDANT HEALTH INC | 13 | 13 | 0.21% | 0.96% | 1.74% | Q3 2020 | Q3 2023 | 13 |
VRAY | VIEWRAY INC | 10 | 3 | 0.01% | 0.75% | 2.08% | Q1 2017 | Q2 2020 | 13 |
FULC | FULCRUM THERAPEUTICS INC | 13 | 13 | 0.22% | 0.72% | 1.77% | Q3 2020 | Q3 2023 | 13 |
PMVP | PMV PHARMACEUTICALS INC | 13 | 13 | 0.25% | 0.70% | 1.67% | Q3 2020 | Q3 2023 | 13 |
ODT | ODONATE THERAPEUTICS INC | 13 | 13 | 0.32% | 0.51% | 1.13% | Q4 2017 | Q4 2020 | 13 |
OM | OUTSET MED INC | 13 | 13 | 0.19% | 0.48% | 0.84% | Q3 2020 | Q3 2023 | 13 |
TELA | TELA BIO INC | 13 | 13 | 0.08% | 0.32% | 0.56% | Q4 2019 | Q4 2022 | 13 |
IMUX | IMMUNIC INC | 13 | 13 | 0.11% | 0.24% | 0.63% | Q3 2020 | Q3 2023 | 13 |
IMTX | IMMATICS N.V | 13 | 13 | 0.06% | 0.10% | 0.21% | Q3 2020 | Q3 2023 | 13 |
GBT | Global Blood Therapeut... | 11 | 1 | 0.14% | 1.14% | 3.95% | Q3 2015 | Q1 2020 | 12 |
TARS | TARSUS PHARMACEUTICALS... | 12 | 12 | 0.65% | 0.90% | 1.66% | Q4 2020 | Q3 2023 | 12 |
QURE | UNIQURE NV | 12 | 12 | 0.14% | 0.68% | 1.32% | Q4 2017 | Q3 2020 | 12 |
OYST | OYSTER PT PHARMA INC | 12 | 12 | 0.23% | 0.67% | 1.55% | Q1 2020 | Q4 2022 | 12 |
IMCR | IMMUNOCORE HLDGS PLC | 11 | 11 | 0.62% | 3.50% | 6.88% | Q1 2021 | Q3 2023 | 11 |
FIXX | HOMOLOGY MEDICINES INC | 11 | 11 | 0.33% | 1.97% | 3.40% | Q1 2018 | Q3 2020 | 11 |
TNDM | TANDEM DIABETES CARE INC | 11 | 11 | 0.36% | 1.61% | 2.55% | Q1 2020 | Q3 2022 | 11 |
OSUR | ORASURE TECHNOLOGIES INC | 5 | 1 | 0.03% | 1.01% | 2.76% | Q3 2015 | Q4 2021 | 11 |
OLK | OLINK HLDG AB | 11 | 11 | 0.05% | 0.35% | 0.65% | Q1 2021 | Q3 2023 | 11 |
ARYD | ARYA SCIENCES ACQU COR... | 11 | 11 | 0.03% | 0.08% | 0.13% | Q1 2021 | Q3 2023 | 11 |
BLUE | bluebird bio Inc | 7 | 3 | 1.80% | 3.91% | 9.05% | Q1 2015 | Q3 2017 | 10 |
SRPT | SAREPTA THERAPEUTICS INC | 9 | 1 | 0.77% | 3.78% | 9.33% | Q1 2018 | Q4 2021 | 10 |
PEN | PENUMBRA INC | 9 | 1 | 0.35% | 2.78% | 4.41% | Q4 2020 | Q3 2023 | 10 |
CUTR | CUTERA INC | 10 | 10 | 0.24% | 1.13% | 2.18% | Q2 2021 | Q3 2023 | 10 |
BLU | BELLUS HEALTH INC NEW | 10 | 10 | 0.23% | 0.93% | 2.36% | Q3 2019 | Q4 2021 | 10 |
NSTG | NANOSTRING TECHNOLOGIE... | 10 | 10 | 0.29% | 0.73% | 1.10% | Q4 2019 | Q1 2022 | 10 |
GHRS | GH RESEARCH PLC | 10 | 10 | 0.36% | 0.60% | 0.82% | Q2 2021 | Q3 2023 | 10 |
MDXG | MIMEDX GROUP INC | 10 | 10 | 0.03% | 0.43% | 0.86% | Q3 2019 | Q4 2021 | 10 |
CLSD | CLEARSIDE BIOMEDICAL INC | 10 | 10 | 0.14% | 0.24% | 0.41% | Q3 2019 | Q4 2021 | 10 |
MOTS | MOTUS GI HLDGS INC | 10 | 10 | 0.02% | 0.07% | 0.18% | Q1 2018 | Q2 2020 | 10 |
AKYA | AKOYA BIOSCIENCES INC | 10 | 10 | 0.02% | 0.05% | 0.13% | Q2 2021 | Q3 2023 | 10 |
MIRO | MIROMATRIX MED INC | 10 | 10 | 0.01% | 0.02% | 0.05% | Q2 2021 | Q3 2023 | 10 |
AVXS | Avexis Inc | 9 | 9 | 2.78% | 8.32% | 15.25% | Q1 2016 | Q1 2018 | 9 |
TMO | THERMO FISHER SCIENTIF... | 9 | 9 | 2.88% | 4.22% | 6.11% | Q3 2021 | Q3 2023 | 9 |
RXDX | PROMETHEUS BIOSCIENCES... | 9 | 9 | 0.81% | 3.19% | 7.53% | Q1 2021 | Q1 2023 | 9 |
GMED | GLOBUS MED INC | 9 | 9 | 1.03% | 1.71% | 2.57% | Q4 2020 | Q4 2022 | 9 |
TBIO | TRANSLATE BIO INC | 9 | 9 | 0.92% | 1.35% | 1.87% | Q1 2019 | Q1 2021 | 9 |
CCCC | C4 THERAPEUTICS INC | 9 | 9 | 0.34% | 1.14% | 2.28% | Q4 2020 | Q4 2022 | 9 |
ISEE | IVERIC BIO INC | 7 | 2 | 0.36% | 1.01% | 1.65% | Q2 2020 | Q4 2022 | 9 |
MGNX | MACROGENICS INC | 9 | 9 | 0.30% | 0.83% | 1.26% | Q2 2020 | Q2 2022 | 9 |
IVTY | Invuity Inc | 9 | 9 | 0.04% | 0.77% | 1.63% | Q2 2015 | Q2 2017 | 9 |
LUNG | PULMONX CORP | 9 | 9 | 0.05% | 0.54% | 1.26% | Q4 2020 | Q4 2022 | 9 |
INMD | INMODE LTD | 9 | 9 | 0.10% | 0.23% | 0.37% | Q3 2019 | Q3 2021 | 9 |
URGN | UROGEN PHARMA LTD | 9 | 9 | 0.12% | 0.18% | 0.25% | Q3 2021 | Q3 2023 | 9 |
PSNL | PERSONALIS INC | 9 | 9 | 0.05% | 0.13% | 0.33% | Q2 2019 | Q2 2021 | 9 |
MASS | 908 DEVICES INC | 9 | 9 | 0.02% | 0.06% | 0.27% | Q4 2020 | Q4 2022 | 9 |
INCY | Incyte Corp | 5 | 1 | 0.72% | 6.17% | 10.72% | Q2 2015 | Q3 2020 | 8 |
ARWR | Arrowhead Pharmaceutic... | 6 | 1 | 0.34% | 3.92% | 8.73% | Q3 2016 | Q4 2021 | 8 |
ATRA | Atara Biotherapeutics ... | 5 | 3 | 1.68% | 3.07% | 4.92% | Q4 2015 | Q4 2017 | 8 |
RARE | ULTRAGENYX PHARMACEUTI... | 8 | 8 | 1.69% | 3.03% | 4.75% | Q4 2021 | Q3 2023 | 8 |
FPRX | Five Prime Therapeutic... | 6 | 1 | 0.37% | 2.09% | 4.05% | Q2 2015 | Q4 2020 | 8 |
CLDX | Celldex Therapeutics I... | 8 | 8 | 0.23% | 1.80% | 3.46% | Q2 2015 | Q1 2017 | 8 |
ARVN | ARVINAS INC | 6 | 2 | 0.16% | 1.12% | 2.55% | Q1 2019 | Q1 2021 | 8 |
ACET | ADICET BIO INC | 8 | 8 | 0.12% | 0.81% | 1.49% | Q4 2021 | Q3 2023 | 8 |
BPMX | Biopharmx Corp | 8 | 8 | 0.12% | 0.19% | 0.28% | Q2 2015 | Q1 2017 | 8 |
ROIVANT SCIENCES LTD | 8 | 8 | 0.06% | 0.17% | 0.38% | Q4 2021 | Q3 2023 | 8 | |
BLSA | BCLS ACQUISITION CORP | 8 | 8 | 0.09% | 0.11% | 0.16% | Q4 2020 | Q3 2022 | 8 |
FVAM | 5 01 ACQUISITION CORP | 8 | 8 | 0.06% | 0.07% | 0.10% | Q4 2020 | Q3 2022 | 8 |
TWST | TWIST BIOSCIENCE CORP | 7 | 1 | 0.02% | 0.06% | 0.24% | Q1 2020 | Q2 2022 | 8 |
OMER | Omeros Corp | 6 | 1 | 0.97% | 3.03% | 9.45% | Q3 2015 | Q2 2017 | 7 |
ITOS | ITEOS THERAPEUTICS INC | 7 | 7 | 0.33% | 0.88% | 1.60% | Q3 2020 | Q1 2022 | 7 |
ATHA | ATHIRA PHARMA INC | 7 | 7 | 0.27% | 0.69% | 1.49% | Q3 2020 | Q1 2022 | 7 |
CYTR | CYTRX CORP | 7 | 7 | 0.33% | 0.52% | 0.86% | Q4 2014 | Q2 2016 | 7 |
CDNA | CAREDX INC | 7 | 7 | 0.21% | 0.50% | 0.77% | Q1 2018 | Q3 2019 | 7 |
SLDB | SOLID BIOSCIENCES INC | 7 | 7 | 0.04% | 0.48% | 1.64% | Q1 2018 | Q3 2019 | 7 |
EPIX | ESSA PHARMA INC | 7 | 7 | 0.06% | 0.42% | 1.32% | Q1 2021 | Q3 2022 | 7 |
LABP | LANDOS BIOPHARMA INC | 7 | 7 | 0.06% | 0.41% | 0.94% | Q1 2021 | Q3 2022 | 7 |
GLUE | MONTE ROSA THERAPEUTIC... | 7 | 7 | 0.19% | 0.32% | 0.39% | Q2 2021 | Q4 2022 | 7 |
SIGHT SCIENCES INC | 7 | 7 | 0.01% | 0.21% | 0.44% | Q3 2021 | Q1 2023 | 7 | |
Vivus Inc 4.5 05/01/2020 | 6 | 1 | 0.11% | 0.19% | 0.30% | Q2 2018 | Q1 2020 | 7 | |
RACB | RESEARCH ALLIANCE CORP II | 7 | 7 | 0.09% | 0.12% | 0.16% | Q1 2021 | Q3 2022 | 7 |
SMIHU | SUMMIT HEALTHCRE ACQUI... | 7 | 7 | 0.07% | 0.10% | 0.13% | Q2 2021 | Q4 2022 | 7 |
ASLN | ASLAN PHARMACEUTICALS LTD | 7 | 7 | 0.04% | 0.09% | 0.17% | Q1 2021 | Q3 2022 | 7 |
NAUT | NAUTILUS BIOTECHNOLOGY... | 7 | 7 | 0.02% | 0.08% | 0.16% | Q2 2021 | Q4 2022 | 7 |
NVLS | Nivalis Therapeutics Inc | 7 | 7 | 0.02% | 0.07% | 0.13% | Q2 2015 | Q4 2016 | 7 |
MSAC | MEDICUS SCIENCES ACQUI... | 7 | 7 | 0.04% | 0.06% | 0.08% | Q2 2021 | Q4 2022 | 7 |
PROF | Profound Medical Corp | 7 | 7 | 0.03% | 0.06% | 0.10% | Q1 2020 | Q3 2021 | 7 |
MSACW | MEDICUS SCIENCES ACQUI... | 7 | 7 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2022 | 7 |
KITE | Kite Pharma Inc | 6 | 6 | 4.88% | 7.08% | 9.78% | Q1 2015 | Q2 2016 | 6 |
IMVT | Immunovant Inc | 6 | 6 | 1.59% | 3.85% | 6.36% | Q4 2019 | Q1 2021 | 6 |
ACAD | ACADIA PHARMACEUTICALS... | 6 | 6 | 1.19% | 2.82% | 5.09% | Q2 2022 | Q3 2023 | 6 |
OXFD | Oxford Immunotec Globa... | 6 | 6 | 0.88% | 2.23% | 3.06% | Q3 2016 | Q4 2017 | 6 |
TCMD | Tactile Systems Techno... | 6 | 6 | 1.02% | 1.57% | 2.24% | Q3 2016 | Q4 2017 | 6 |
VENTYX BIOSCIENCES INC | 6 | 6 | 0.44% | 0.77% | 1.25% | Q4 2021 | Q1 2023 | 6 | |
LPCN | LIPOCINE INC NEW | 6 | 6 | 0.41% | 0.70% | 0.94% | Q4 2014 | Q1 2016 | 6 |
TENAYA THERAPEUTICS INC | 6 | 6 | 0.10% | 0.44% | 0.73% | Q3 2021 | Q4 2022 | 6 | |
TMDX | TRANSMEDICS GROUP INC | 6 | 6 | 0.17% | 0.42% | 0.78% | Q2 2019 | Q3 2020 | 6 |
JNCE | JOUNCE THERAPEUTICS INC | 6 | 6 | 0.12% | 0.32% | 0.66% | Q3 2021 | Q4 2022 | 6 |
GTH | GENETRON HLDGS LTD | 6 | 6 | 0.05% | 0.29% | 0.61% | Q1 2021 | Q2 2022 | 6 |
MOONLAKE IMMUNOTHERAPE... | 6 | 6 | 0.07% | 0.26% | 0.60% | Q2 2022 | Q3 2023 | 6 | |
AADI BIOSCIENCES INC | 6 | 6 | 0.20% | 0.26% | 0.32% | Q3 2021 | Q4 2022 | 6 | |
ADAP | Adaptimmune Therapeuti... | 4 | 2 | 0.02% | 0.24% | 0.73% | Q2 2015 | Q3 2020 | 6 |
STIM | NEURONETICS INC | 6 | 6 | 0.08% | 0.22% | 0.36% | Q2 2018 | Q3 2019 | 6 |
ITMR | ITAMAR MED LTD | 6 | 6 | 0.08% | 0.16% | 0.24% | Q1 2020 | Q2 2021 | 6 |
ARYA SCIENCES ACQUISIT... | 6 | 6 | 0.07% | 0.10% | 0.13% | Q3 2021 | Q4 2022 | 6 | |
NYXOAH S A | 6 | 6 | 0.03% | 0.09% | 0.15% | Q3 2021 | Q4 2022 | 6 | |
RCEL | AVITA MEDICAL INC | 6 | 6 | 0.01% | 0.05% | 0.09% | Q1 2021 | Q2 2022 | 6 |
BNR | BURNING ROCK BIOTECH LTD | 6 | 6 | 0.01% | 0.01% | 0.02% | Q2 2020 | Q3 2021 | 6 |
DYAX | DYAX CORP | 5 | 5 | 0.68% | 5.90% | 11.99% | Q4 2014 | Q4 2015 | 5 |
LIVN | LivaNova PLC | 5 | 5 | 1.18% | 2.85% | 3.77% | Q1 2018 | Q1 2019 | 5 |
SSRG | Symmetry Surgical Inc | 5 | 5 | 1.78% | 2.82% | 4.14% | Q2 2015 | Q2 2016 | 5 |
FREQ | Frequency Therapeutics... | 5 | 5 | 0.82% | 1.28% | 1.59% | Q4 2019 | Q4 2020 | 5 |
IDYA | IDEAYA BIOSCIENCES INC | 5 | 5 | 0.43% | 0.90% | 1.26% | Q4 2020 | Q4 2021 | 5 |
PRNB | PRINCIPIA BIOPHARMA INC | 5 | 5 | 0.46% | 0.87% | 1.32% | Q3 2018 | Q3 2019 | 5 |
BCYC | BICYCLE THERAPEUTICS PLC | 5 | 5 | 0.55% | 0.79% | 1.16% | Q4 2021 | Q4 2022 | 5 |
BVX | Bovie Medical Corp | 5 | 5 | 0.55% | 0.72% | 0.95% | Q3 2017 | Q3 2018 | 5 |
PTI | Proteostasis Therapeut... | 5 | 5 | 0.10% | 0.49% | 1.46% | Q4 2017 | Q4 2018 | 5 |
SCIENCE 37 HOLDINGS INC | 5 | 5 | 0.02% | 0.32% | 0.72% | Q4 2021 | Q4 2022 | 5 | |
BLI | BERKELEY LTS INC | 5 | 5 | 0.08% | 0.30% | 0.55% | Q3 2020 | Q3 2021 | 5 |
RENOVACOR INC | 5 | 5 | 0.16% | 0.24% | 0.30% | Q3 2021 | Q3 2022 | 5 | |
CERE | CEREVEL THERAPEUTICS H... | 5 | 5 | 0.11% | 0.21% | 0.32% | Q4 2020 | Q4 2021 | 5 |
AFIB | ACUTUS MED INC | 5 | 5 | 0.07% | 0.16% | 0.32% | Q3 2020 | Q3 2021 | 5 |
VINC | VINCERX PHARMA INC | 5 | 5 | 0.11% | 0.15% | 0.18% | Q4 2020 | Q4 2021 | 5 |
PHGE | Biomx Inc | 5 | 5 | 0.06% | 0.13% | 0.22% | Q4 2019 | Q4 2020 | 5 |
CNTB | Connect Biopharma Hold... | 5 | 5 | 0.03% | 0.10% | 0.16% | Q1 2021 | Q1 2022 | 5 |
CHAQU | CHARDAN HEALTHCR ACQST... | 5 | 5 | 0.06% | 0.07% | 0.10% | Q2 2020 | Q2 2021 | 5 |
DNAY | CODEX DNA INC | 5 | 5 | 0.01% | 0.03% | 0.07% | Q2 2021 | Q2 2022 | 5 |
PROG | PROGENITY INC | 5 | 5 | 0.01% | 0.03% | 0.07% | Q2 2020 | Q2 2021 | 5 |
SRTSW | SENSUS HEATLHCARE INC | 5 | 5 | 0.02% | 0.02% | 0.04% | Q4 2016 | Q4 2017 | 5 |
OMIC | SINGULAR GENOMICS SYST... | 5 | 5 | 0.01% | 0.02% | 0.04% | Q2 2021 | Q2 2022 | 5 |
PHGEWS | BIOMX Inc | 5 | 5 | 0.01% | 0.01% | 0.02% | Q4 2019 | Q4 2020 | 5 |
RENOVACOR INC | 5 | 5 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2022 | 5 | |
SPY | SPDR S&P 500 ETF TR | 4 | 4 | 5.65% | 6.03% | 6.44% | Q1 2021 | Q4 2021 | 4 |
CERN | Cerner Corp | 4 | 4 | 1.99% | 2.23% | 2.42% | Q2 2020 | Q1 2021 | 4 |
FLDM | FLUIDIGM CORP DEL | 4 | 4 | 0.58% | 1.10% | 1.75% | Q4 2018 | Q3 2019 | 4 |
WVE | WAVE Life Sciences Ltd | 3 | 1 | 0.52% | 0.94% | 1.37% | Q1 2019 | Q2 2020 | 4 |
RPRX | REPROS THERAPEUTICS INC | 4 | 4 | 0.48% | 0.69% | 0.89% | Q4 2014 | Q3 2015 | 4 |
CINCOR PHARMA INC | 4 | 4 | 0.35% | 0.65% | 1.05% | Q1 2022 | Q4 2022 | 4 | |
TRILLIUM THERAPEUTICS INC | 4 | 4 | 0.31% | 0.48% | 0.74% | Q3 2020 | Q2 2021 | 4 | |
CHACU | CHARDAN HEALTHCARE ACQ... | 4 | 4 | 0.33% | 0.43% | 0.56% | Q4 2018 | Q3 2019 | 4 |
ECOR | ELECTROCORE INC | 4 | 4 | 0.25% | 0.40% | 0.60% | Q2 2018 | Q1 2019 | 4 |
VKTX | VIKING THERAPEUTICS INC | 3 | 1 | 0.06% | 0.31% | 0.52% | Q3 2018 | Q3 2023 | 4 |
NEO | NEOGENOMICS INC | 3 | 1 | 0.16% | 0.24% | 0.39% | Q2 2020 | Q4 2021 | 4 |
MNKD | MNKD 01/20/2017 PUT 3 | 4 | 4 | 0.08% | 0.21% | 0.33% | Q1 2016 | Q4 2016 | 4 |
LSAQ | LIFESCI ACQUISITION II... | 4 | 4 | 0.10% | 0.13% | 0.15% | Q4 2020 | Q3 2021 | 4 |
HLXA | HELIX ACQUISITION CORP | 4 | 4 | 0.11% | 0.12% | 0.14% | Q4 2020 | Q3 2021 | 4 |
MRVI | MARAVAI LIFESCIENCES H... | 3 | 1 | 0.03% | 0.12% | 0.36% | Q4 2020 | Q2 2023 | 4 |
APVO | APTEVO THERAPEUTICS INC | 4 | 4 | 0.07% | 0.12% | 0.18% | Q4 2020 | Q3 2021 | 4 |
BCTG | BCTG ACQUISITION CORP | 4 | 4 | 0.10% | 0.12% | 0.15% | Q3 2020 | Q2 2021 | 4 |
RACA | Therapeutics Acquisiti... | 4 | 4 | 0.08% | 0.11% | 0.17% | Q3 2020 | Q2 2021 | 4 |
PROCEPT BIOROBOTICS CORP | 4 | 4 | 0.07% | 0.11% | 0.14% | Q3 2021 | Q2 2022 | 4 | |
SRRK | Scholar Rock Holding Corp | 4 | 4 | 0.07% | 0.10% | 0.14% | Q4 2020 | Q3 2021 | 4 |
PNT | POINT BIOPHARMA GLOBAL... | 4 | 4 | 0.04% | 0.07% | 0.09% | Q3 2021 | Q2 2022 | 4 |
MAXCYTE INC | 4 | 4 | 0.03% | 0.05% | 0.09% | Q3 2021 | Q2 2022 | 4 | |
OPTN | OPTINOSE INC | 4 | 4 | 0.03% | 0.04% | 0.06% | Q4 2018 | Q3 2019 | 4 |
RXSIGHT INC | 4 | 4 | 0.02% | 0.04% | 0.06% | Q3 2021 | Q2 2022 | 4 | |
BOLT | BOLT BIOTHERAPEUTICS INC | 4 | 4 | 0.01% | 0.03% | 0.08% | Q1 2021 | Q4 2021 | 4 |
ZY | ZYMERGEN INC | 4 | 4 | 0.00% | 0.02% | 0.04% | Q2 2021 | Q1 2022 | 4 |
BRKB | Berkshire Hathaway Inc | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q1 2016 | 4 |
ARWR | ARROWHEAD RESH CORP | 3 | 3 | 5.33% | 6.60% | 7.36% | Q4 2014 | Q2 2015 | 3 |
MDCO | Medicines Co | 3 | 3 | 1.40% | 4.52% | 7.37% | Q3 2016 | Q1 2017 | 3 |
BRKR | BRUKER CORP | 3 | 3 | 1.95% | 3.52% | 4.44% | Q1 2023 | Q3 2023 | 3 |
ZBH | Zimmer Biomet Holdings... | 3 | 3 | 2.47% | 2.89% | 3.29% | Q3 2019 | Q1 2020 | 3 |
TRGT | TARGACEPT INC | 3 | 3 | 2.16% | 2.78% | 3.57% | Q4 2014 | Q2 2015 | 3 |
TLT | iShares 20+ Year Treas... | 2 | 1 | 1.13% | 1.56% | 2.14% | Q2 2015 | Q2 2016 | 3 |
QDEL | QUIDEL CORP | 2 | 1 | 0.64% | 1.37% | 1.76% | Q3 2019 | Q2 2021 | 3 |
ORCHESTRA BIOMED HLDGS... | 3 | 3 | 0.75% | 1.29% | 2.09% | Q1 2023 | Q3 2023 | 3 | |
ASMB | ASSEMBLY BIOSCIENCES INC | 2 | 1 | 0.59% | 1.09% | 1.45% | Q4 2014 | Q4 2018 | 3 |
KIDS | ORTHOPEDIATRICS CORP | 3 | 3 | 0.73% | 0.94% | 1.29% | Q4 2018 | Q2 2019 | 3 |
LENS | Presbia Plc | 3 | 3 | 0.60% | 0.87% | 1.17% | Q1 2015 | Q3 2015 | 3 |
PODD | Insulet Corp | 2 | 1 | 0.44% | 0.72% | 1.09% | Q2 2017 | Q4 2019 | 3 |
QTRX | QUANTERIX CORP | 3 | 3 | 0.42% | 0.65% | 0.76% | Q4 2021 | Q2 2022 | 3 |
STAA | STAAR Surgical Co | 3 | 3 | 0.40% | 0.62% | 0.94% | Q4 2019 | Q2 2020 | 3 |
SCPH | SCPHARMACEUTICALS INC | 3 | 3 | 0.50% | 0.59% | 0.64% | Q1 2023 | Q3 2023 | 3 |
AXDX | Accelerate Diagnostics... | 3 | 3 | 0.37% | 0.58% | 0.76% | Q4 2015 | Q2 2016 | 3 |
MRUS | MERUS N V | 2 | 1 | 0.09% | 0.54% | 0.99% | Q4 2021 | Q3 2023 | 3 |
NVTRQ | Nuvectra Corp | 3 | 3 | 0.33% | 0.51% | 0.63% | Q1 2018 | Q3 2018 | 3 |
2SEVENTY BIO INC | 3 | 3 | 0.41% | 0.42% | 0.43% | Q1 2022 | Q3 2022 | 3 | |
NVAX | Novavax Inc | 3 | 3 | 0.26% | 0.37% | 0.54% | Q1 2018 | Q3 2018 | 3 |
GNMK | GenMark Diagnostics Inc | 3 | 3 | 0.19% | 0.28% | 0.39% | Q2 2020 | Q4 2020 | 3 |
MINERALYS THERAPEUTICS... | 3 | 3 | 0.18% | 0.26% | 0.30% | Q1 2023 | Q3 2023 | 3 | |
ALLK | ALLAKOS INC | 3 | 3 | 0.12% | 0.21% | 0.28% | Q3 2022 | Q1 2023 | 3 |
MDRX | Allscripts Healthcare ... | 2 | 1 | 0.18% | 0.21% | 0.23% | Q3 2015 | Q2 2016 | 3 |
SRTS | Sensus Heatlhcare Inc | 3 | 3 | 0.10% | 0.19% | 0.24% | Q3 2016 | Q1 2017 | 3 |
PYXIS ONCOLOGY INC | 3 | 3 | 0.04% | 0.19% | 0.34% | Q4 2021 | Q2 2022 | 3 | |
LSACU | Lifesci Acquisition Corp | 3 | 3 | 0.16% | 0.18% | 0.22% | Q1 2020 | Q3 2020 | 3 |
BMEA | BIOMEA FUSION INC | 3 | 3 | 0.06% | 0.13% | 0.18% | Q2 2021 | Q4 2021 | 3 |
NVUS | Novus Therapeutics Inc | 3 | 3 | 0.09% | 0.13% | 0.15% | Q1 2018 | Q3 2018 | 3 |
THIRD HARMONIC BIO INC | 3 | 3 | 0.05% | 0.12% | 0.27% | Q3 2022 | Q1 2023 | 3 | |
ARYA | Arya Sciences Acquisit... | 3 | 3 | 0.09% | 0.11% | 0.13% | Q3 2020 | Q1 2021 | 3 |
SOPHIA GENETICS SA | 3 | 3 | 0.04% | 0.06% | 0.08% | Q3 2021 | Q1 2022 | 3 | |
BDSX | BIODESIX INC | 3 | 3 | 0.02% | 0.04% | 0.04% | Q4 2020 | Q2 2021 | 3 |
FLGT | Fulgent Genetics Inc | 3 | 3 | 0.03% | 0.04% | 0.04% | Q4 2019 | Q2 2020 | 3 |
ISOPLEXIS CORP | 3 | 3 | 0.02% | 0.03% | 0.05% | Q4 2021 | Q2 2022 | 3 | |
APEN | APOLLO ENDOSURGERY INC | 3 | 3 | 0.02% | 0.03% | 0.03% | Q4 2021 | Q2 2022 | 3 |
AZYO | AZIYO BIOLOGICS INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q4 2020 | Q2 2021 | 3 |
CEREW | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.01% | 0.02% | 0.04% | Q4 2020 | Q2 2021 | 3 |
MINERVA SURGICAL INC | 3 | 3 | 0.01% | 0.01% | 0.02% | Q4 2021 | Q2 2022 | 3 | |
ROCKET PHARMACEUTICALS... | 3 | 3 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q3 2023 | 3 | |
TARO | Taro Pharmaceutical In... | 2 | 2 | 0.56% | 7.62% | 14.69% | Q4 2014 | Q1 2015 | 2 |
ZSPH | ZS PHARMA INC | 2 | 2 | 1.36% | 3.56% | 5.76% | Q4 2014 | Q1 2015 | 2 |
GLD | SPDR Gold Trust | 2 | 2 | 3.15% | 3.37% | 3.59% | Q2 2016 | Q3 2016 | 2 |
RLYP | RELYPSA INC | 2 | 2 | 0.52% | 2.82% | 5.13% | Q4 2014 | Q1 2015 | 2 |
Atara Biotherapeutics ... | 1 | 1 | 2.57% | 2.76% | 2.96% | Q3 2015 | Q3 2016 | 2 | |
BAX | Baxter Intl Inc | 2 | 2 | 2.09% | 2.22% | 2.35% | Q2 2020 | Q3 2020 | 2 |
EW | Edwards Lifesciences Corp | 2 | 2 | 1.93% | 2.12% | 2.31% | Q4 2017 | Q1 2018 | 2 |
USO | United States Oil Fund LP | 1 | 1 | 0.96% | 1.97% | 2.98% | Q2 2015 | Q4 2016 | 2 |
SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 1.48% | 1.86% | 2.24% | Q4 2018 | Q3 2023 | 2 |
SIBN | SI BONE INC | 2 | 2 | 1.56% | 1.60% | 1.63% | Q4 2018 | Q1 2019 | 2 |
QGEN | Qiagen NV | 2 | 2 | 1.38% | 1.57% | 1.76% | Q2 2018 | Q3 2018 | 2 |
CNCE | Concert Pharmaceutical... | 2 | 2 | 0.92% | 1.16% | 1.39% | Q4 2018 | Q1 2019 | 2 |
JJOFF | Barclays Bank Plc | 2 | 2 | 1.09% | 1.15% | 1.21% | Q2 2016 | Q3 2016 | 2 |
AAVL | AVALANCHE BIOTECHNOLOG... | 2 | 2 | 0.94% | 0.97% | 1.00% | Q4 2014 | Q1 2015 | 2 |
MDGL | MADRIGAL PHARMACEUTICA... | 2 | 2 | 0.95% | 0.96% | 0.97% | Q2 2023 | Q3 2023 | 2 |
NLNK | NewLink Genetics Corp | 2 | 2 | 0.32% | 0.80% | 1.29% | Q2 2015 | Q3 2015 | 2 |
SBPH | Spring Bk Pharmaceutic... | 2 | 2 | 0.71% | 0.72% | 0.73% | Q2 2017 | Q3 2017 | 2 |
APLS | APELLIS PHARMACEUTICAL... | 2 | 2 | 0.05% | 0.71% | 1.37% | Q4 2021 | Q1 2022 | 2 |
KURA | Kura Oncology Inc | 2 | 2 | 0.48% | 0.70% | 0.93% | Q4 2020 | Q1 2021 | 2 |
INSM | INSMED INC | 2 | 2 | 0.40% | 0.70% | 0.99% | Q2 2023 | Q3 2023 | 2 |
QTNT | QUOTIENT LTD | 2 | 2 | 0.59% | 0.68% | 0.77% | Q2 2019 | Q3 2019 | 2 |
MYGN | MYRIAD GENETICS INC | 2 | 2 | 0.56% | 0.58% | 0.61% | Q1 2019 | Q2 2019 | 2 |
CRIS | Curis Inc | 2 | 2 | 0.51% | 0.58% | 0.64% | Q4 2020 | Q1 2021 | 2 |
SILK | SILK ROAD MEDICAL INC | 2 | 2 | 0.47% | 0.53% | 0.58% | Q2 2019 | Q3 2019 | 2 |
ZYNE | Zynerba Pharmaceutical... | 2 | 2 | 0.29% | 0.36% | 0.42% | Q3 2017 | Q4 2017 | 2 |
AMRS | Amyris Inc | 2 | 2 | 0.35% | 0.36% | 0.36% | Q2 2020 | Q3 2020 | 2 |
ACELYRIN INC | 2 | 2 | 0.21% | 0.30% | 0.39% | Q2 2023 | Q3 2023 | 2 | |
HSAQ | HEALTH SCIENCES ACQ CO... | 2 | 2 | 0.20% | 0.22% | 0.23% | Q3 2022 | Q4 2022 | 2 |
VIVUS INC | 1 | 1 | 0.19% | 0.21% | 0.24% | Q1 2018 | Q3 2018 | 2 | |
DSGN | DESIGN THERAPEUTICS INC | 2 | 2 | 0.12% | 0.16% | 0.19% | Q2 2023 | Q3 2023 | 2 |
ARYBU | ARYA Sciences Acquisti... | 2 | 2 | 0.13% | 0.15% | 0.16% | Q2 2020 | Q3 2020 | 2 |
CHAQ | CHARDAN HEALTHCR ACQST... | 2 | 2 | 0.12% | 0.13% | 0.13% | Q1 2021 | Q2 2021 | 2 |
TPIV | Tapimmune Inc | 2 | 2 | 0.11% | 0.12% | 0.14% | Q2 2018 | Q3 2018 | 2 |
BOLD | Audentes Therapeutics Inc | 2 | 2 | 0.11% | 0.12% | 0.14% | Q3 2016 | Q4 2016 | 2 |
RMED | RA MED SYS INC | 2 | 2 | 0.04% | 0.08% | 0.12% | Q3 2018 | Q4 2018 | 2 |
PANAU | Panacea Acquisition Corp | 2 | 2 | 0.06% | 0.08% | 0.09% | Q3 2020 | Q4 2020 | 2 |
TANGO THERAPEUTICS INC | 2 | 2 | 0.03% | 0.07% | 0.12% | Q3 2021 | Q4 2021 | 2 | |
BLCM | Bellicum Pharmaceutica... | 2 | 2 | 0.06% | 0.07% | 0.08% | Q2 2018 | Q3 2018 | 2 |
LPTN | LPATH INC | 2 | 2 | 0.06% | 0.06% | 0.07% | Q4 2014 | Q1 2015 | 2 |
CVRX | CVRX INC | 2 | 2 | 0.04% | 0.05% | 0.06% | Q2 2021 | Q3 2021 | 2 |
SEMA4 HOLDINGS CORP | 2 | 2 | 0.03% | 0.04% | 0.04% | Q3 2021 | Q4 2021 | 2 | |
VINCW | Vincerx Pharma Inc wts... | 2 | 2 | 0.03% | 0.03% | 0.03% | Q4 2020 | Q1 2021 | 2 |
VIVO | VIVO 01/15/2016 CALL 20 | 2 | 2 | 0.02% | 0.03% | 0.04% | Q3 2015 | Q4 2015 | 2 |
ANCN | ANCHIANO THERAPEUTICS LTD | 2 | 2 | 0.01% | 0.02% | 0.03% | Q1 2019 | Q2 2019 | 2 |
NVRO | NVRO 05/20/2016 PUT 50 | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2015 | Q1 2016 | 2 |
USO | USO 01/15/2016 CALL 25 | 2 | 2 | 0.00% | 0.01% | 0.01% | Q3 2015 | Q4 2015 | 2 |
BCAB | Bioatla Inc | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q1 2021 | 2 |
SEER | Seer Inc | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2020 | Q1 2021 | 2 |
La Jolla Pharmaceutica... | 1 | 1 | 5.57% | 5.57% | 5.57% | Q2 2015 | Q2 2015 | 1 | |
Arrowhead Research Corp | 1 | 1 | 3.75% | 3.75% | 3.75% | Q3 2015 | Q3 2015 | 1 | |
XNPT | XENOPORT INC | 1 | 1 | 2.73% | 2.73% | 2.73% | Q4 2014 | Q4 2014 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 2.65% | 2.65% | 2.65% | Q4 2014 | Q4 2014 | 1 |
HRTX | Heron Therapeutics Inc | 1 | 1 | 2.01% | 2.01% | 2.01% | Q3 2016 | Q3 2016 | 1 |
HZNP | HORIZON THERAPEUTICS P... | 1 | 1 | 1.96% | 1.96% | 1.96% | Q2 2023 | Q2 2023 | 1 |
ICPT | Intercept Pharmaceutic... | 1 | 1 | 1.93% | 1.93% | 1.93% | Q2 2016 | Q2 2016 | 1 |
Bristol Myers Squibb C... | 1 | 1 | 1.78% | 1.78% | 1.78% | Q2 2015 | Q2 2015 | 1 | |
ARMO | Armo Biosciences Inc | 1 | 1 | 1.33% | 1.33% | 1.33% | Q1 2018 | Q1 2018 | 1 |
TSHA | TAYSHA GENE THERAPIES INC | 1 | 1 | 1.13% | 1.13% | 1.13% | Q3 2023 | Q3 2023 | 1 |
ISRG | INTUITIVE SURGICAL INC | 1 | 1 | 1.11% | 1.11% | 1.11% | Q2 2023 | Q2 2023 | 1 |
RMD | ResMed Inc | 1 | 1 | 1.02% | 1.02% | 1.02% | Q3 2018 | Q3 2018 | 1 |
APOGEE THERAPEUTICS INC | 1 | 1 | 0.96% | 0.96% | 0.96% | Q3 2023 | Q3 2023 | 1 | |
CNDO | Coronado Biosciences Inc | 1 | 1 | 0.87% | 0.87% | 0.87% | Q1 2015 | Q1 2015 | 1 |
BMY | BMY 01/15/2016 CALL 60 | 1 | 1 | 0.80% | 0.80% | 0.80% | Q3 2015 | Q3 2015 | 1 |
PACB | PACIFIC BIOSCIENCES CA... | 1 | 1 | 0.72% | 0.72% | 0.72% | Q3 2018 | Q3 2018 | 1 |
PTE | Polarityte Inc | 1 | 1 | 0.72% | 0.72% | 0.72% | Q2 2018 | Q2 2018 | 1 |
UHS | Universal Health Servi... | 1 | 1 | 0.66% | 0.66% | 0.66% | Q2 2017 | Q2 2017 | 1 |
VERU | VERU INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q2 2022 | Q2 2022 | 1 |
PLX | PROTALIX BIOTHERAPEUTI... | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2014 | Q4 2014 | 1 |
VXRT | Vaxart Inc | 1 | 1 | 0.56% | 0.56% | 0.56% | Q3 2020 | Q3 2020 | 1 |
CBIO | Catalyst Biosciences Inc | 1 | 1 | 0.55% | 0.55% | 0.55% | Q3 2015 | Q3 2015 | 1 |
VBIV | Vbi Vaccines Inc | 1 | 1 | 0.53% | 0.53% | 0.53% | Q3 2015 | Q3 2015 | 1 |
ALKS | ALKERMES PLC | 1 | 1 | 0.52% | 0.52% | 0.52% | Q3 2023 | Q3 2023 | 1 |
SWAV | SHOCKWAVE MED INC | 1 | 1 | 0.52% | 0.52% | 0.52% | Q3 2023 | Q3 2023 | 1 |
A | Agilent Technologies Inc | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2019 | Q4 2019 | 1 |
ALT | Altimmune Inc | 1 | 1 | 0.42% | 0.42% | 0.42% | Q3 2020 | Q3 2020 | 1 |
OCX | Oncocyte Corporation | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2019 | Q1 2019 | 1 |
SRTSU | Sensus Healthcare Inc | 1 | 1 | 0.34% | 0.34% | 0.34% | Q2 2016 | Q2 2016 | 1 |
ALLURION TECHNOLOGIES INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2023 | Q3 2023 | 1 | |
NVAX | NOVAVAX INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2016 | Q3 2016 | 1 |
SNSS | Sunesis Pharmaceutical... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2019 | Q3 2019 | 1 |
CYRX | CRYOPORT INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2022 | Q2 2022 | 1 |
ARCT | Arcturus Therapeutics Ltd | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2020 | Q3 2020 | 1 |
ALGN | ALIGN TECHNOLOGY INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2022 | Q2 2022 | 1 |
CYTEK BIOSCIENCES INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2022 | Q2 2022 | 1 | |
CDXS | CODEXIS INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2022 | Q2 2022 | 1 |
SOMALOGIC INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2022 | Q2 2022 | 1 | |
NVRO | NEVRO CORP | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2014 | Q4 2014 | 1 |
TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2022 | Q4 2022 | 1 |
RPTX | Repare Therapeutics Inc | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2020 | Q2 2020 | 1 |
BDTX | BLACK DIAMOND THERAPEU... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2023 | Q2 2023 | 1 |
SYK | STRYKER CORPORATION | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2023 | Q3 2023 | 1 |
EQ | Equillium Inc | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2020 | Q3 2020 | 1 |
RVNC | Revance Therapeutics Inc | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2017 | Q4 2017 | 1 |
BCRX | BCRX 12/18/2015 CALL 12 | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2015 | Q3 2015 | 1 |
GHDX | Genomic Health Inc | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2015 | Q3 2015 | 1 |
JASPER THERAPEUTICS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2023 | Q1 2023 | 1 | |
Meridian Bioscience In... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2015 | Q2 2015 | 1 | |
SAGIMET BIOSCIENCES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2023 | Q3 2023 | 1 | |
CTIC | CTI BIOPHARMA CORP | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2022 | Q2 2022 | 1 |
LIVN | LIVANOVA PLC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2018 | Q4 2018 | 1 |
NARI | Inari Med Inc | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2020 | Q2 2020 | 1 |
ELGX | Endologix Inc | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2015 | Q3 2015 | 1 |
ZGNX | Zogenix Inc | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2015 | Q2 2015 | 1 |
NUVB | Nuvation Bio Inc | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
MAAC | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2021 | Q3 2021 | 1 |
MSACU | Medicus Sciences Acqui... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
MRSN | MERSANA THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2023 | Q2 2023 | 1 |
VCYT | Veracyte Inc | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2015 | Q3 2015 | 1 |
ABEO | Abeona Therapeutics Inc | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2016 | Q3 2016 | 1 |
MINK THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 | |
Valeant Pharmaceutical... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2015 | Q2 2015 | 1 | |
RAYZEBIO INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 | |
SIENTRA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 | |
LVGO | Livongo Health Inc | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q3 2019 | 1 |
FBIO | Fortress Biotech Inc | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
YS BIOPHARMA CO LTD | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q1 2023 | 1 | |
SHAK | Shake Shack Inc | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2015 | Q1 2015 | 1 |
TENX | Tenax Therapeutics Inc | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q1 2015 | 1 |
NUVBWS | Nuvation Bio Inc | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q1 2021 | 1 |
Berkshire Hathaway Inc | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 | |
ACHL | ACHILLES THERAPEUTICS PLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q4 2021 | 1 |
Download |
The securities at the top of the list , including ALNYLAM PHARMACEUTICALS INC, MASIMO CORP, and LA JOLLA PHARMACEUTICAL CO, are the highest-conviction holdings of RTW INVESTMENTS, LP.
The conviction is calculated by counting the number of quarters a security has been reported by RTW INVESTMENTS, LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that RTW INVESTMENTS, LP owns currently or has owned in the past.